Ars Investment Partners, LLC Red Hill Biopharma Ltd. Transaction History
Ars Investment Partners, LLC
- $976 Million
- Q3 2024
Shares
6 transactions
Others Institutions Holding RDHL
# of Institutions
2Shares Held
40.4KCall Options Held
0Put Options Held
0About RedHill Biopharma Ltd.
- Ticker RDHL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 63,823,500
- Market Cap $412M
- Description
- RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...